According to a recent LinkedIn post from DESKi, the company is drawing attention to what it describes as a 66-point access gap in U.S. heart screening, citing survey data that 96% of Americans view local heart screening as important while only 30% say they can easily access it. The post indicates that patients may be open to alternatives beyond hospitals, including retail clinics, walk-in centers, and primary care settings.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests a market opportunity for more convenient cardiovascular screening infrastructure, potentially leveraging technologies such as point-of-care ultrasound and AI-driven diagnostics referenced via its hashtags. For investors, this emphasis on convenience and preventive care could imply DESKi is positioning itself toward scalable, decentralized screening solutions, which may align with broader trends in medtech and value-based care, though the post does not provide specific product, revenue, or partnership details.